Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Entamoeba histolytica develops resistance to complement deposition and lysis after acquisition of human complement regulatory proteins through trogocytosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.04.455151Source: DataRank Database

Entamoeba histolytica develops resistance to complement deposition and lysis after acquisition of human complement regulatory proteins through trogocytosis is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (41)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Tammie S. Y. Tam,Katherine S. Ralston ORCID,Hannah W. Miller

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W3193142328

National Institutes of Health

Grant: 5R01AI146914-05

The role of Entamoeba histolytica trogocytosis (trogo-: nibble) in the pathogenesis of amoebiasis

greenLicense: CC BY

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/10/29/2021.08.04.455151.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.08.04.455151

repositoryhttps://doi.org/10.1101/2021.08.04.455151

https://doi.org/10.1128/mbio.03163-21

Fields of Study

Amoebic Infections and TreatmentsIron Metabolism and DisordersHeme Oxygenase-1 and Carbon Monoxide0301 basic medicine03 medical and health sciences0302 clinical medicine

Keywords

BiologyEntamoeba histolyticaMicrobiologyCD59Complement systemAlternative complement pathwayImmune systemCD46Immunology570610DysenteryBiodefense2.1 Biological and endogenous factorsHumanscomplementtrogocytosisimmune evasionBiomedical and Clinical SciencesCell DeathAmebiasisComplement System ProteinsMedical microbiologyFoodborne IllnessQR1-502Infectious DiseasesEmerging Infectious DiseasesGood Health and Well BeingBiochemistry and cell biologyDysentery, AmebicDigestive DiseasesInfectionAmebicResearch ArticleTranscription Factors

Sustainable Development Goals

SDG 3: 3. Good health